Sodium-glucose cotransporter 2 inhibitors in real-life patients at high cardiovascular risk

被引：0
|
作者：
Cesaro, Arturo [1 ,2 ]
Fimiani, Fabio [1 ,2 ]
Gragnano, Felice [1 ,2 ]
Moscarella, Elisabetta [1 ,2 ]
Signore, Giovanni [1 ,2 ]
Maratea, Anna Chiara [1 ,2 ]
Rotolo, Francesco Paolo [1 ,2 ]
Vergara, Andrea [1 ,2 ]
Schiavo, Alessandra [1 ,2 ]
Calabro, Paolo [1 ,2 ]
机构：
[1] Univ Campania L Vanvitelli, Dept Translat Med Sci, Naples, Italy
[2] Aorn S Anna E S Sebastiano, Div Cardiol, Caserta, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2021年 / 23卷 / SUPPL G期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
785
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sodium-glucose cotransporter 2 inhibitors in real-life patients at high cardiovascular risk
    Cesaro, Arturo
    Fimiani, Fabio
    Gragnano, Felice
    Moscarella, Elisabetta
    Signore, Giovanni
    Maratea, Anna Chiara
    Rotolo, Francesco Paolo
    Vergara, Andrea
    Schiavo, Alessandra
    Calabro, Paolo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [2] Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes
    Steinberg, Helmut O.
    POSTGRADUATE MEDICINE, 2016, 128 (04) : 398 - 408
  • [3] Real-Life Individual Comparison of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure and Diabetes Mellitus
    Yilmaz, Mehmet Birhan
    Celik, Ahmet
    Colluoglu, Tugce
    Sahin, Anil
    Ural, Dilek
    Kanik, Arzu
    Ata, Naim
    Ulgu, Mustafa Mahir
    Birinci, Suayip
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (02) : 277 - 286
  • [4] Sodium-Glucose Cotransporter 2 Inhibition and Cardiovascular Risk
    Liakos A.
    Bekiari E.
    Tsapas A.
    Current Cardiovascular Risk Reports, 2016, 10 (6)
  • [5] Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis
    Kristensen, Kasper B.
    Henriksen, Daniel P.
    Hallas, Jesper
    Pottegard, Anton
    Lund, Lars C.
    DIABETOLOGIA, 2021, 64 (07) : 1563 - 1571
  • [6] Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients
    Xiang, Boyang
    Zhao, Xiaoya
    Zhou, Xiang
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [7] Performance of sodium-glucose cotransporter 2 inhibitors in cardiovascular disease
    Khater, Jacinthe
    Malakouti, Sara
    El Khoury, Antoine
    Cortese, Bernardo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2024, 25 (04) : 247 - 258
  • [8] Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients
    Boyang Xiang
    Xiaoya Zhao
    Xiang Zhou
    Cardiovascular Diabetology, 20
  • [9] Real-Life Evaluation of Sodium-Glucose Cotransporter 2 Inhibition in Type 1 Diabetes
    Stougaard, Elisabeth Buur
    Kristensen, Peter L.
    Kielgast, Urd
    Andersen, Henrik U.
    Hamid, Yasmin H.
    Gaede, Peter
    Sondergaard, Esben
    Dorflinger, Gry
    Fjeldborg, Karen K.
    Hansen, Klavs W.
    Thomsen, Henrik H.
    Al-Imari, Thuraya
    Roder, Michael
    Rossing, Peter
    Persson, Frederik
    DIABETES, 2022, 71
  • [10] Sodium-Glucose Cotransporter 2 Inhibitors
    Erol, Cetin
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (05): : 216 - 216
12345